Department of Neurology, Academic Medical Center, Amsterdam, the Netherlands.
J Thromb Haemost. 2015 Jun;13 Suppl 1:S238-44. doi: 10.1111/jth.12945.
Cerebral venous thrombosis (CVT) is an uncommon cause of stroke that mainly affects young adults and children. In contrast to venous thromboembolism, women are affected three times more often than men. Baseline symptoms can vary considerably between patients, but most present with headache, seizures, or focal neurological deficits. Patients can be diagnosed with magnetic resonance imaging, computerized tomography-venography, or catheter angiography, although the latter is rarely required anymore. Approximately 30-50% of patients have an intracerebral hemorrhage, which can range from a small juxtacortical hemorrhage to large space-occupying lesions. Based on limited evidence from clinical trials, the primary therapy for CVT is anticoagulation with heparin. Uncontrolled studies have shown promising results for the use of endovascular treatment in severely affected patients, but these studies require confirmation in prospective clinical trials. In patients who develop clinical and radiological signs of impending herniation decompressive surgery can be both life saving and result in a good functional outcome.
脑静脉血栓形成(CVT)是一种少见的卒中病因,主要影响青年和儿童。与静脉血栓栓塞不同,女性的发病率是男性的 3 倍。基础症状在不同患者间差异较大,但多数表现为头痛、癫痫发作或局灶性神经功能缺损。患者可通过磁共振成像、计算机断层静脉造影或导管血管造影进行诊断,尽管后者已很少需要。约 30-50%的患者发生颅内出血,范围从小的皮质下出血至大的占位性病变。基于临床试验的有限证据,CVT 的主要治疗方法是肝素抗凝。未受控制的研究显示,血管内治疗对重症患者有良好的效果,但这些研究需要前瞻性临床试验来证实。对于出现即将发生脑疝的临床和影像学征象的患者,减压手术既能挽救生命,又能获得良好的功能结局。